{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T19:04:58Z","timestamp":1772132698736,"version":"3.50.1"},"reference-count":71,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-colorectal-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Colorectal Cancer"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.clcc.2017.06.009","type":"journal-article","created":{"date-parts":[[2017,6,27]],"date-time":"2017-06-27T04:33:18Z","timestamp":1498537998000},"page":"e29-e37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Intestinal and Extraintestinal Cancers Associated With Inflammatory Bowel Disease"],"prefix":"10.1016","volume":"17","author":[{"given":"Minna","family":"Chang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7837-3777","authenticated-orcid":false,"given":"Liisa","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanna M.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuju","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clcc.2017.06.009_bib1","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMra020831","article-title":"Inflammatory bowel disease","volume":"347","author":"Podolsky","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clcc.2017.06.009_bib2","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1053\/j.gastro.2011.10.001","article-title":"Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review","volume":"142","author":"Molodecky","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clcc.2017.06.009_bib3","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cgh.2012.09.026","article-title":"Trends in overall and cause-specific mortality among patients with inflammatory bowel disease from 1982 to 2010","volume":"11","author":"Jess","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clcc.2017.06.009_bib4","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3109\/00365521.2014.992041","article-title":"Malignancies in inflammatory bowel disease","volume":"50","author":"Nieminen","year":"2015","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.clcc.2017.06.009_bib5","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1056\/NEJM199011013231802","article-title":"Ulcerative colitis and colorectal cancer: a population-based study","volume":"323","author":"Ekbom","year":"1990","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clcc.2017.06.009_bib6","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1053\/j.gastro.2013.03.044","article-title":"Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease","volume":"145","author":"Beaugerie","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clcc.2017.06.009_bib7","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1111\/j.1572-0241.2006.00603.x","article-title":"The epidemiology of inflammatory bowel disease in Canada: a population-based study","volume":"101","author":"Bernstein","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clcc.2017.06.009_bib8","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1056\/NEJMra1403718","article-title":"Cancers complicating inflammatory bowel disease","volume":"372","author":"Beaugerie","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clcc.2017.06.009_bib9","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/gut.48.4.526","article-title":"The risk of colorectal cancer in ulcerative colitis: a meta analysis","volume":"48","author":"Eaden","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.clcc.2017.06.009_bib10","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.crohns.2013.01.010","article-title":"The burden of inflammatory bowel disease in Europe","volume":"7","author":"Burisch","year":"2013","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.clcc.2017.06.009_bib11","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.cgh.2012.01.010","article-title":"Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies","volume":"10","author":"Jess","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clcc.2017.06.009_bib12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1055\/s-2006-933561","article-title":"Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer","volume":"26","author":"Broom\u00e9","year":"2006","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.clcc.2017.06.009_bib13","doi-asserted-by":"crossref","first-page":"7327","DOI":"10.3748\/wjg.v19.i42.7327","article-title":"Hepatobiliary manifestations in inflammatory bowel disease: the gut, the drugs and the liver","volume":"19","author":"Rojas-Feria","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clcc.2017.06.009_bib14","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/ecco-jcc\/jjv141","article-title":"European evidence-based consensus: inflammatory bowel disease and malignancies","volume":"9","author":"Annese","year":"2015","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.clcc.2017.06.009_bib15","doi-asserted-by":"crossref","first-page":"338","DOI":"10.5858\/arpa.2012-0086-RA","article-title":"Dysplastic lesions in inflammatory bowel disease: molecular pathogenesis to morphology","volume":"137","author":"Matkowskyj","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.clcc.2017.06.009_bib16","doi-asserted-by":"crossref","first-page":"G7","DOI":"10.1152\/ajpgi.00079.2004","article-title":"Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation","volume":"287","author":"Itzkowitz","year":"2004","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.clcc.2017.06.009_bib17","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.cgh.2013.06.023","article-title":"Inflammation is an independent risk factor for colonic neoplasia in patients with ulcerative colitis: a case-control study","volume":"11","author":"Rubin","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clcc.2017.06.009_bib18","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/carcin\/bgs006","article-title":"Inflammation, DNA methylation and colitis-associated cancer","volume":"33","author":"Hartnett","year":"2012","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.clcc.2017.06.009_bib19","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1053\/j.gastro.2007.08.001","article-title":"Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study","volume":"133","author":"Gupta","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clcc.2017.06.009_bib20","doi-asserted-by":"crossref","first-page":"6774","DOI":"10.3748\/wjg.v20.i22.6774","article-title":"Inflammatory colonic carcinogenesis: a review on pathogenesis and immunosurveillance mechanisms in ulcerative colitis","volume":"20","author":"Scarpa","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clcc.2017.06.009_bib21","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.molcel.2014.03.039","article-title":"The multifaceted role of the intestinal microbiota in colon cancer","volume":"54","author":"Irraz\u00e1bal","year":"2014","journal-title":"Mol Cell"},{"key":"10.1016\/j.clcc.2017.06.009_bib22","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1053\/j.gastro.2014.01.001","article-title":"Gastrointestinal malignancy and the microbiome","volume":"146","author":"Abreu","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clcc.2017.06.009_bib23","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.suc.2015.08.001","article-title":"Colorectal neoplasia and inflammatory bowel disease","volume":"95","author":"Cannon","year":"2015","journal-title":"Surg Clin North Am"},{"key":"10.1016\/j.clcc.2017.06.009_bib24","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00281-016-0613-x","article-title":"Inflammatory bowel disease and cancer response due to anti-CTLA-4: is it in the flora?","volume":"39","author":"Carbonnel","year":"2017","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.clcc.2017.06.009_bib25","doi-asserted-by":"crossref","first-page":"4794","DOI":"10.3748\/wjg.v22.i20.4794","article-title":"Inflammatory bowel disease and cancer: the role of inflammation, immunosuppression, and cancer treatment","volume":"22","author":"Axelrad","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clcc.2017.06.009_bib26","first-page":"14","article-title":"Evaluation of transplant candidates with pre-existing malignancies","volume":"2","author":"Penn","year":"1997","journal-title":"Ann Transplant"},{"key":"10.1016\/j.clcc.2017.06.009_bib27","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.2174\/1389450115666140821113330","article-title":"Management of inflammatory bowel disease patients with a cancer history","volume":"15","author":"Beaugerie","year":"2014","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.clcc.2017.06.009_bib28","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.3748\/wjg.v20.i12.3164","article-title":"Microscopic features of colorectal neoplasia in inflammatory bowel diseases","volume":"20","author":"Bressenot","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clcc.2017.06.009_bib29","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/his.12565","article-title":"Current issues in inflammatory bowel disease neoplasia","volume":"66","author":"Vieth","year":"2015","journal-title":"Histopathology"},{"key":"10.1016\/j.clcc.2017.06.009_bib30","first-page":"3184","article-title":"Cancer risk in IBD: how to diagnose and how to manage DALM and ALM","volume":"17","author":"Neumann","year":"2011","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clcc.2017.06.009_bib31","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1053\/j.gastro.2009.12.035","article-title":"AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease","volume":"138","author":"Farraye","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clcc.2017.06.009_bib32","doi-asserted-by":"crossref","first-page":"961","DOI":"10.3748\/wjg.v22.i3.961","article-title":"Inflammatory bowel disease associated neoplasia: a surgeon's perspective","volume":"22","author":"Althumairi","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clcc.2017.06.009_bib33","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1053\/j.gastro.2011.12.004","article-title":"Field cancerization in the intestinal epithelium of patients with Crohn's ileocolitis","volume":"142","author":"Galandiuk","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clcc.2017.06.009_bib34","doi-asserted-by":"crossref","first-page":"509","DOI":"10.5946\/ce.2014.47.6.509","article-title":"Colon cancer screening and surveillance in inflammatory bowel disease","volume":"47","author":"Bae","year":"2014","journal-title":"Clin Endosc"},{"key":"10.1016\/j.clcc.2017.06.009_bib35","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.bpg.2016.10.014","article-title":"Surveillance of patients with inflammatory bowel disease","volume":"30","author":"Yu","year":"2016","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.clcc.2017.06.009_bib36","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1053\/j.gastro.2009.12.037","article-title":"AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease","volume":"138","author":"Farraye","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clcc.2017.06.009_bib37","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/ajg.2009.727","article-title":"Ulcerative colitis practice guidelines in adults: American College of Gastroenterology, Practice Parameters Committee","volume":"105","author":"Kornbluth","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clcc.2017.06.009_bib38","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.gie.2006.02.005","article-title":"ASGE guideline: endoscopy in the diagnosis and treatment of inflammatory bowel disease","volume":"63","author":"Leighton","year":"2006","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.clcc.2017.06.009_bib39","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1053\/j.gastro.2015.01.031","article-title":"SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease","volume":"148","author":"Laine","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clcc.2017.06.009_bib40","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.crohns.2013.09.016","article-title":"European evidence based consensus for endoscopy in inflammatory bowel disease","volume":"7","author":"Annese","year":"2013","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.clcc.2017.06.009_bib41","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1136\/gut.2009.179804","article-title":"Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002)","volume":"59","author":"Cairns","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.clcc.2017.06.009_bib42","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1136\/gut.2003.016386","article-title":"Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis","volume":"53","author":"Rutter","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.clcc.2017.06.009_bib43","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.cgh.2015.11.011","article-title":"Chromoendoscopy is more effective than standard colonoscopy in detecting dysplasia during long-term surveillance of patients with colitis","volume":"14","author":"Marion","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clcc.2017.06.009_bib44","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000366037","article-title":"Chemoprevention of colorectal cancer","volume":"33","author":"Lang","year":"2015","journal-title":"Dig Dis"},{"key":"10.1016\/j.clcc.2017.06.009_bib45","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1111\/j.1572-0241.2005.00287.x","article-title":"Increased risk of intestinal cancer in Crohn's disease: a meta-analysis of population-based cohort studies","volume":"100","author":"Jess","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clcc.2017.06.009_bib46","first-page":"1823","article-title":"Incidence, presentation, and prognosis of small bowel adenocarcinoma in patients with small bowel Crohn's disease: a prospective observational study","volume":"19","author":"Elriz","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.clcc.2017.06.009_bib47","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s10350-006-0848-z","article-title":"The risk of cancer in patients with Crohn's disease","volume":"50","author":"von Roon","year":"2007","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.clcc.2017.06.009_bib48","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1097\/MIB.0000000000000112","article-title":"Small bowel adenocarcinomas complicating Crohn's disease are associated with dysplasia: a pathological and molecular study","volume":"20","author":"Svrcek","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.clcc.2017.06.009_bib49","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1002\/ibd.22889","article-title":"Excess primary intestinal lymphoproliferative disorders in patients with inflammatory bowel disease","volume":"18","author":"Sokol","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.clcc.2017.06.009_bib50","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/path.1442","article-title":"Epstein-Barr virus infection in colorectal neoplasms associated with inflammatory bowel disease: detection of the virus in lymphomas but not in adenocarcinomas","volume":"201","author":"Wong","year":"2003","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.clcc.2017.06.009_bib51","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/DCR.0b013e318197d0ad","article-title":"Cancer of the anus complicating perianal Crohn's disease","volume":"52","author":"Devon","year":"2009","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.clcc.2017.06.009_bib52","first-page":"1","article-title":"An update on cancer risk and surveillance in primary sclerosing cholangitis","author":"Horsley-Silva","year":"2016","journal-title":"Liver Int"},{"key":"10.1016\/j.clcc.2017.06.009_bib53","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.dld.2010.01.011","article-title":"Update on primary sclerosing cholangitis","volume":"42","author":"Karlsen","year":"2010","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.clcc.2017.06.009_bib54","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/MEG.0000000000000532","article-title":"Primary sclerosing cholangitis associated with inflammatory bowel disease: an update","volume":"28","author":"Rossi","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.clcc.2017.06.009_bib55","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1136\/gutjnl-2013-305763","article-title":"Risk of new or recurrent cancer under immunosuppressive therapy in patients with IBD and previous cancer","volume":"63","author":"Beaugerie","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.clcc.2017.06.009_bib56","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1093\/aje\/kws375","article-title":"Use of azathioprine\u00a0and\u00a0the risk of cancer in inflammatory bowel disease","volume":"177","author":"Pasternak","year":"2013","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.clcc.2017.06.009_bib57","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1038\/ajg.2009.760","article-title":"Risk of extra-intestinal cancer in inflammatory bowel disease: meta-analysis of population-based cohort studies","volume":"105","author":"Pedersen","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clcc.2017.06.009_bib58","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.diii.2015.02.009","article-title":"Extra-intestinal malignancies in inflammatory bowel diseases: an update with emphasis on MDCT and MR imaging features","volume":"96","author":"Dohan","year":"2015","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.clcc.2017.06.009_bib59","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.2165\/00003495-200767080-00006","article-title":"Immunosuppressive therapy and malignancy in organ transplant recipients: a systematic review","volume":"67","author":"Gutierrez-Dalmau","year":"2007","journal-title":"Drugs"},{"key":"10.1016\/j.clcc.2017.06.009_bib60","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/S0140-6736(09)61302-7","article-title":"Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study","volume":"374","author":"Beaugerie","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.clcc.2017.06.009_bib61","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.cgh.2014.05.015","article-title":"Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis","volume":"13","author":"Kotlyar","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clcc.2017.06.009_bib62","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cgh.2010.09.016","article-title":"A\u00a0systematic review of factors that contribute to hepatosplenic T-cell lymphoma in patients with inflammatory bowel disease","volume":"9","author":"Kotlyar","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clcc.2017.06.009_bib63","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1053\/j.gastro.2011.06.050","article-title":"Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease","volume":"141","author":"Peyrin-Biroulet","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clcc.2017.06.009_bib64","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/ajg.2013.451","article-title":"Association between thiopurine use and nonmelanoma skin cancers in patients with inflammatory bowel disease: a meta-analysis","volume":"109","author":"Ariyaratnam","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clcc.2017.06.009_bib65","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1053\/j.gastro.2012.05.004","article-title":"Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease","volume":"143","author":"Long","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clcc.2017.06.009_bib66","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1001\/jama.2014.5613","article-title":"Association between tumor necrosis factor-\u03b1 antagonists and risk of cancer in patients with inflammatory bowel disease","volume":"311","author":"Nyboe Andersen","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.clcc.2017.06.009_bib67","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1572-0241.2007.01582.x","article-title":"Higher incidence of abnormal Pap smears in women with inflammatory bowel disease","volume":"103","author":"Kane","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clcc.2017.06.009_bib68","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1097\/MIB.0000000000000338","article-title":"Are patients with inflammatory bowel disease on chronic immunosuppressive therapy at increased risk of cervical high-grade dysplasia\/cancer? A meta-analysis","volume":"21","author":"Allegretti","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.clcc.2017.06.009_bib69","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrc3878","article-title":"Milestones of Lynch syndrome: 1895-2015","volume":"15","author":"Lynch","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.clcc.2017.06.009_bib70","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1056\/NEJMra012242","article-title":"Hereditary colorectal cancer","volume":"348","author":"Lynch","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clcc.2017.06.009_bib71","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","article-title":"PD-1 Blockade in tumors with mismatch-repair deficiency","volume":"372","author":"Le","year":"2015","journal-title":"N\u00a0Engl J Med"}],"container-title":["Clinical Colorectal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002817301524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002817301524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T23:05:05Z","timestamp":1761519905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1533002817301524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S1533002817301524"],"URL":"https:\/\/doi.org\/10.1016\/j.clcc.2017.06.009","relation":{},"ISSN":["1533-0028"],"issn-type":[{"value":"1533-0028","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intestinal and Extraintestinal Cancers Associated With Inflammatory Bowel Disease","name":"articletitle","label":"Article Title"},{"value":"Clinical Colorectal Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clcc.2017.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}